Monday, 7 August 2023

North America In Vitro Diagnostics Market Outlook Growth Emerging Factors On Geography, Technological Advancements And Mounting Demand Forecast To 2030

 North America In Vitro Diagnostics Market Growth & Trends

The North America in vitro diagnostics market size is expected to reach USD 39.67 billion by 2030 and is expected to decline at 2.89% CAGR from 2023 to 2030, according to a new report by Grand View Research, Inc. On the other hand, the market is also expected to cater to various growth opportunities in key segments. For example, the development of automated in vitro diagnostic solutions for hospitals and laboratories to provide accurate, efficient, and error-free diagnosis is anticipated to drive market growth in the coming years. In addition, rising efforts to develop POC solutions and the surge in adoption of POC tests across different medical diagnostic applications, including infectious diseases, pregnancy, cancer, and others, are fueling the market growth.

The market growth is likely to be fueled by rising efforts from leading participants to develop fast and accurate products that allow easy-to-use, advanced, and flexible testing options. For instance, in August 2022, DxGen Corp. and Precision Diabetes, Inc. announced an agreement to develop and launch a fully automatic POC analyzer in the U.S. market to measure a complete profile of diabetes tests. The analyzer is capable to test C-reactive protein, urine analysis, A1C levels, and other diabetes confirmatory tests at POC facilities.

North America In Vitro Diagnostics Market Report Scope

Report Attribute

Details

Market size value in 2023

USD 48.19 billion

Revenue forecast in 2030

USD 39.67 billion

Growth rate

CAGR of -2.89% from 2023 to 2030

Base year for estimation

2022

Historical data

2018 - 2021

Forecast period

2023 - 2030

Furthermore, in November 2021, Lumos Diagnostics, a key player in POC diagnostics, announced that its Lumos CoviDx SARS-CoV-2 Rapid Antigen Test received an interim order authorization from Health Canada. This test offers easy-to-interpret outcomes in just 15-20 minutes in serial testing of asymptomatic patients. The easy availability of point-of-care tests in home care settings, community pharmacies, retail health clinics, urgent care centers, intensive care units, and operating rooms is fueling the adoption of POC IVD products across the region.

The North America in vitro diagnostics industry is gaining traction as diagnostic laboratories frequently employ fully automated tools. Moreover, automated devices are highly scalable, meet a high level of performance expectations, eliminate batch testing, and provide quick results to medical professionals. Leading participants are continuously working on building automated devices because of these benefits. For instance, in May 2022, BD launched a new, fully automated high-throughput infectious disease molecular diagnostics platform in the U.S. market.

Furthermore, the increasing incidence of target diseases, favorable government initiatives, and the flourishing healthcare sector in the region are anticipated to offer lucrative growth opportunities.

For instance, in November 2022, Hologic, Inc. was awarded a USD 19 million contract from BARDA to support its research and development activities. In addition, in January 2022, Aline, Inc. & Nectar Product Development announced a strategic partnership to improve POC in vitro diagnostic products.

Request a free sample copy or view report summary: North America In Vitro Diagnostics Market Report

North America In Vitro Diagnostics Market Report Highlights

  • The reagents segment held the largest market share in 2022 owing to extensive R&D initiatives being undertaken by major market players for the development of novel test kits
  • The molecular diagnostics segment accounted for the largest market share in 2022, thanks to rapid evolution in technology, increasing burden of target diseases, and surge in product launches by leading participants
  • Based on application, the infectious disease segment dominated the market in terms of revenue share in 2022. On the other hand, the oncology segment is expected to be the fastest-growing segment over the forecast period
  • The hospitals segment was the largest end-user in 2022, owing to the rising demand for affordable services, the surging trend for personalized treatments, and the presence of favorable reimbursement policies
  • Canada is expected to exhibit the fastest growth over the forecast period in the region due to the increasing geriatric population, and large patient pool with a high prevalence of chronic diseases

Access Press Release@ https://www.grandviewresearch.com/press-release/north-america-in-vitro-diagnostics-market-analysis

North America In Vitro Diagnostics Market Segmentation

Grand View Research has segmented the North America in vitro diagnostics market based on product, technology, application, end-use, test location, and country:

North America In Vitro Diagnostics Product Outlook (Volume, Number of Tests and Instruments; Revenue, USD Million, 2018 - 2030)

  • Instruments
    • End-use
      • Hospitals
      • Laboratories
      • Home Care
      • Clinic/Others
        • Physician Office
        • Pharmacy & Retail Clinics
        • Non-practice Clinics
        • Urgent Care Clinics
        • Others
      • Reagents
        • End-use
          • Hospitals
          • Laboratories
          • Home Care
          • Clinic/Others
            • Physician Office
            • Pharmacy & Retail Clinics
            • Non-practice Clinics
            • Urgent Care Clinics
            • Others
          • Services
            • End-use
              • Hospitals
              • Laboratories
              • Home Care
              • Clinic/Others
                • Physician Office
                • Pharmacy & Retail Clinics
                • Non-practice Clinics
                • Urgent Care Clinics
                • Others

North America In Vitro Diagnostics Technology Outlook (Volume, Number of Tests and Instruments; Revenue, USD Million, 2018 - 2030)

  • Immunoassay
    • Product
      • Instruments
      • Reagents
      • Services
    • End-use
      • Hospitals
      • Laboratories
      • Home Care
      • Clinic/Others
        • Physician Office
        • Pharmacy & Retail Clinics
        • Non-practice Clinics
        • Urgent Care Clinics
        • Others
      • Hematology
        • Product
          • Instruments
          • Reagents
          • Services
        • End-use
          • Hospitals
          • Laboratories
          • Home Care
          • Clinic/Others
            • Physician Office
            • Pharmacy & Retail Clinics
            • Non-practice Clinics
            • Urgent Care Clinics
            • Others
          • Clinical Chemistry
            • Product
              • Instruments
              • Reagents
              • Services
            • End-use
              • Hospitals
              • Laboratories
              • Home Care
              • Clinic/Others
                • Physician Office
                • Pharmacy & Retail Clinics
                • Non-practice Clinics
                • Urgent Care Clinics
                • Others
              • Molecular Diagnostics
                • Product
                  • Instruments
                  • Reagents
                  • Services
                • End-use
                  • Hospitals
                  • Laboratories
                  • Home Care
                  • Clinic/Others
                    • Physician Office
                    • Pharmacy & Retail Clinics
                    • Non-practice Clinics
                    • Urgent Care Clinics
                    • Others
                  • Coagulation
                    • Product
                      • Instruments
                      • Reagents
                      • Services
                    • End-use
                      • Hospitals
                      • Laboratories
                      • Home Care
                      • Clinic/Others
                        • Physician Office
                        • Pharmacy & Retail Clinics
                        • Non-practice Clinics
                        • Urgent Care Clinics
                        • Others
                      • Microbiology
                        • Product
                          • Instruments
                          • Reagents
                          • Services
                        • End-use
                          • Hospitals
                          • Laboratories
                          • Home Care
                          • Clinic/Others
                            • Physician Office
                            • Pharmacy & Retail Clinics
                            • Non-practice Clinics
                            • Urgent Care Clinics
                            • Others
                          • Others
                            • Product
                              • Instruments
                              • Reagents
                              • Services
                            • End-use
                              • Hospitals
                              • Laboratories
                              • Home Care
                              • Clinic/Others
                                • Physician Office
                                • Pharmacy & Retail Clinics
                                • Non-practice Clinics
                                • Urgent Care Clinics
                                • Others

North America In Vitro Diagnostics Application Outlook (Volume, Number of Tests and Instruments; Revenue, USD Million, 2018 - 2030)

  • Infectious Disease
    • Disease
      • Methicillin-resistant Staphylococcus Aureus (MRSA)
      • Clostridium Difficile
      • Vancomycin-resistant Enterococci (VRE)
      • Carbapenem-resistant Bacteria
      • Flu
      • Respiratory Syncytial Virus (RSV)
      • Candida
      • Tuberculosis and Drug-resistant TBA
      • Meningitis
      • Gastrointestinal Panel Testing
      • Chlamydia
      • Gonorrhea
      • HIV
      • Hepatitis C
      • Hepatitis B
      • Other Infectious Diseases
    • End-use
      • Hospitals
      • Laboratories
      • Home Care
      • Clinic/Others
        • Physician Office
        • Pharmacy & Retail Clinics
        • Non-practice Clinics
        • Urgent Care Clinics
        • Others
      • Diabetes
        • End-use
          • Hospitals
          • Laboratories
          • Home Care
          • Clinic/Others
            • Physician Office
            • Pharmacy & Retail Clinics
            • Non-practice Clinics
            • Urgent Care Clinics
            • Others
          • Oncology
            • Disease
              • Breast Cancer
              • Prostate Cancer
              • Colorectal Cancer
              • Cervical Cancer
              • Kidney Cancer
              • Liver Cancer
              • Blood Cancer
              • Lung Cancer
              • Other Cancer
            • End-Use
              • Hospitals
              • Laboratories
              • Home Care
              • Clinic/Others
                • Physician Office
                • Pharmacy & Retail Clinics
                • Non-practice Clinics
                • Urgent Care Clinics
                • Others
              • Cardiology
                • Disease
                  • Coronary Heart Disease
                  • Stroke
                  • Peripheral Arterial Disease
                  • Aortic Disease
                  • Others
                • End-use
                  • Hospitals
                  • Laboratories
                  • Home Care
                  • Clinic/Others
                    • Physician Office
                    • Pharmacy & Retail Clinics
                    • Non-practice Clinics
                    • Urgent Care Clinics
                    • Others
                  • Nephrology
                    • Disease
                      • UTI
                      • Kidney Disease
                      • Diabetes
                      • Others
                    • End-use
                      • Hospitals
                      • Laboratories
                      • Home Care
                      • Clinic/Others
                        • Physician Office
                        • Pharmacy & Retail Clinics
                        • Non-practice Clinics
                        • Urgent Care Clinics
                        • Others
                      • Autoimmune Diseases
                        • Disease
                          • Rheumatoid Arthritis
                          • Inflammatory Bowel Disease
                          • Osteoporosis
                          • Celiac Disease
                          • Fibromyalgia
                        • End-use
                          • Hospitals
                          • Laboratories
                          • Home Care
                          • Clinic/Others
                            • Physician Office
                            • Pharmacy & Retail Clinics
                            • Non-practice Clinics
                            • Urgent Care Clinics
                            • Others
                          • Drug Testing
                            • End-use
                              • Hospitals
                              • Laboratories
                              • Home Care
                              • Clinic/Others
                                • Physician Office
                                • Pharmacy & Retail Clinics
                                • Non-practice Clinics
                                • Urgent Care Clinics
                                • Others
                              • Others
                                • End-use
                                  • Hospitals
                                  • Laboratories
                                  • Home Care
                                  • Clinic/Others
                                    • Physician Office
                                    • Pharmacy & Retail Clinics
                                    • Non-practice Clinics
                                    • Urgent Care Clinics
                                    • Others

North America In Vitro Diagnostics End-use Outlook (Volume, Number of Tests and Instruments; Revenue, USD Million, 2018 - 2030)

  • Hospitals
  • Laboratories
  • Home Care
  • Clinic/Others
    • Physician Office
    • Pharmacy & Retail Clinics
    • Non-practice Clinics
    • Urgent Care Clinics
    • Others

North America In Vitro Diagnostics Test Location Outlook (Revenue, USD Million, 2018 - 2030)

  • Point-of-Care
  • Others

North America In Vitro Diagnostics Regional Outlook (Revenue, USD Million, 2018 - 2030)

  • North America
    • US.
    • Canada

List of Key Players in the North America In Vitro Diagnostics Market

  • Abbott
  • bioMérieux SA
  • Bio-Rad Laboratories, Inc.
  • BD
  • Siemens Healthcare GmbH
  • QIAGEN
  • Quidel Corporation
  • Hoffmann-La Roche Ltd
  • Sysmex Corporation
  • Charles River Laboratories International, Inc.
  • Quest Diagnostics
  • Agilent Technologies, Inc.
  • Danaher

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Friday, 4 August 2023

Global Demand for Dermatology CRO Market to Incur Considerable Upsurge During 2023– 2030: Grand View Research Inc.

 

Dermatology CRO Market Growth & Trends

The global dermatology CRO market size is expected to reach USD 8,057.9 million by 2030, registering a CAGR of 6.8% over the forecast period, according to a new report by Grand View Research, Inc. Rising influx of contract research organizations (CROs) to mitigate the disease burden associated with dermatological conditions is a key driver for this market. Moreover, the rising demand for topical dermatological medications, such as anti-infective, anti-inflammatory agents, local anesthetics, emollients, and cleansers, to cure acne are major factors driving the market growth. High demand for speedy diagnosis, an increase in the prevalence of skin cancer and other skin problems, and increased awareness regarding skin diseases are major factors boosting the market growth.

An increase in cases of skin disease across the globe is expected to propel the market growth in the forecast period. Atopic dermatitis is one of the most common inflammatory skin diseases, affecting around 5-10% of individuals in the U.S. Around one in three individuals in the country with atopic dermatitis have moderate-to-severe disease. Moreover, skin cancer is the most common cancer in the U.S. According to the American Academy of Dermatology, around 1 in 5 individuals would develop skin cancer in their lifetime. In addition, it is estimated that around 9500 individuals in the country are diagnosed with skin cancer every day. The COVID-19 pandemic significantly impacted the market.

Clinical trials in numerous therapeutic fields, including dermatology, were impacted by the COVID-19 pandemic. Several clinical trials were temporarily delayed or halted, impacting the timelines and progress of research studies. This disruption is expected to affect the growth and revenue of dermatology CROs, as their services are closely tied to clinical trial activities. Furthermore, patent expiration in the dermatology industry and growing investment in R&D programs are key factors anticipated to drive market growth in the coming years. For instance, in February 2022, Recipharm acquired CDMO Arranta Bio to expand its mRNA biologics offerings in the U.S. This acquisition is expected to improve the company's capabilities in developing medications in the area of cancer, psoriasis, infectious diseases, and other diseases.

Request a free sample copy or view report summary: Dermatology CRO Market Report

Dermatology CRO Market Report Highlights

  • Based on type, the clinical segment accounted for the largest revenue share of 76.10% in 2022. This is attributed to the globalization of clinical trials, technological advancements, and an increase in demand for dermatology CROs to conduct clinical trials
  • Based on service type, the regulatory/medical affairs segment is expected to show a significant market share in the forecast period. Increasing demand to obtain approval for new products and differences in drug regulations globally are some of the major factors driving the segment growth
  • Asia Pacific captured the largest revenue share of over 43.29% in 2022. This is due to the diversity in population, high prevalence of skin disorders, improving regulatory framework, and, the ease with which patients may be recruited and retained
  • A post-covid surge in clinical trials provided a lucrative opportunity for CROs to enter the dermatology space. For instance, in January 2022, Vial started providing dermatology outsourcing services via its arm Vial Dermatology CRO. Wherein, they partnered with 35 dermatology clinics in the U.S. to provide faster clinical trials

Access Press Release@ https://www.grandviewresearch.com/press-release/global-dermatology-cro-market

Dermatology CRO Market Segmentation

Grand View Research has segmented the global dermatology CRO market based on type, service type, and region:

Dermatology CRO Type Outlook (Revenue, USD Million, 2018 - 2030)

  • Drug Discovery
    • Target Validation
    • Lead Identification
    • Lead optimization
  • Preclinical
  • Clinical
    • Phase I
    • Phase II
    • Phase III
    • Phase IV

Dermatology CRO Service Outlook (Revenue, USD Million, 2018 - 2030)

  • Project Management/Clinical Supply Management
  • Data Management
  • Regulatory/Medical Affairs
  • Medical Writing
  • Clinical Monitoring
  • Quality Management/Assurance
  • Bio-statistics
  • Investigator Payments
  • Laboratory
  • Patient and Site Recruitment
  • Technology
  • Others

Dermatology CRO Regional Outlook (Revenue, USD Million, 2018 - 2030)

  • North America
    • US.
    • Canada
  • Europe
    • UK
    • Germany
    • France
    • Italy
    • Spain
    • Denmark
    • Sweden
    • Norway
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • South Korea
    • Thailand
  • Latin America
    • Brazil
    • Mexico
    • Argentina
    • Colombia
    • Chile
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE
    • Israel
    • Iran
    • Kuwait

List of Key Players of Dermatology CRO Market

  • IQVIA HOLDINGS INC.
  • Covance Inc.
  • Pharmaceutical Product Development, LLC (PPD)
  • Parexel International Corporation
  • Charles River Laboratories International, Inc.
  • Icon, Plc
  • Syneos Health
  • Wuxi AppTec
  • Bioskin
  • Proinnovera

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

North America Packaged Salad Market to Reflect Robust Expansion During 2021-2028: Grand View Research Inc.

 North America Packaged Salad Market Growth & Trends

The North America packaged salad market size is expected to reach USD 10.0 billion by 2028, according to a new report by Grand View Research, Inc. The market is expected to expand at a CAGR of 7.8% from 2021 to 2028. Rising health consciousness among consumers and a growing inclination toward convenience foods are expected to be the major factors contributing to the growth of the market.

The branded category segment led the market in 2020. Branded packaged salads are salads that are widely available nationally or internationally and are not limited to one retailer or region. Retail channels usually trade both branded and private label packaged salads to take advantage of exclusive products.

Vegetarian products are most popular among customers and the demand for vegetarian packaged salads is being pushed by the rising number of health-conscious consumers in North America. Individuals searching for organic produce/products continue to create a large demand for vegetarian packed salads in this regard.

The U.S. dominated the North American market in 2020. With the increasing awareness about leading a healthy lifestyle, the demand for packaged salads has been growing significantly among consumers. Furthermore, the high penetration of key market players in the U.S. has improved product accessibility across the country.

The market players face stiff competition from each other as some of them are among the top frozen bakery manufacturers and have a large customer base. The market is fragmented with the presence of a large number of global and regional players such as Earthbound Farm; Vegpro International Inc.; Dole Food Company, Inc.; and Fresh Express Incorporated.

Request a free sample copy or view report summary: North America Packaged Salad Market Report

North America Packaged Salad Market Report Highlights

  • Canada is projected to register the fastest growth rate of 9.2% from 2021 to 2028 due to increasing awareness regarding the health benefits of eating salads as a part of the daily diet
  • By type, packaged kits are expected to expand at the fastest CAGR of 8.0% from 2021 to 2028 due to the growing consumption of healthy meal alternative products that are healthy and contain less fat
  • The offline distribution channel held the largest share of over 80.0% in 2020as supermarkets offer significant advantages to consumers, such as the freedom of selection, lower prices, and the high visibility of international brands

Access Press Release@ https://www.grandviewresearch.com/press-release/north-america-packaged-salad-market-analysis

North America Packaged Salad Market Segmentation

Grand View Research has segmented the North America packaged salad market on the basis of category, product, processing, type, distribution channel, and country:

North America Packaged Salad Category Outlook (Revenue, USD Million, 2016 - 2028)

  • Branded
  • In-store/Private Label

North America Packaged Salad Product Outlook (Revenue, USD Million, 2016 - 2028)

  • Vegetarian
  • Non-vegetarian

North America Packaged Salad Processing Outlook (Revenue, USD Million, 2016 - 2028)

  • Organic
  • Conventional

North America Packaged Salad Type Outlook (Revenue, USD Million, 2016 - 2028)

  • Packaged Greens
  • Packaged Kits

North America Packaged Salad Distribution Channel Outlook (Revenue, USD Million, 2016 - 2028)

  • Online
  • Offline

North America Packaged Salad Country Outlook (Revenue, USD Million, 2016 - 2028)

  • US.
    • Florida
    • New York
    • Pennsylvania
    • Illinois
    • Ohio
    • Georgia
  • Canada
    • Quebec
    • British Colombia
    • Ontario
    • Alberta
    • Rest of Canada

List of Key Players of North America Packaged Salad Market

  • Earthbound Farm
  • Vegpro International Inc.
  • Dole Food Company, Inc.
  • Fresh Express Incorporated
  • BrightFarms
  • Eat Smart
  • Misionero
  • Gotham Greens Holdings, LLC
  • Mann Packing Co.
  • Bonduelle

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Automotive Powertrain Market Soaring Demand Assures Motivated Revenue Share By 2025

 Automotive Powertrain Market Growth & Trends

The global automotive powertrain market size is expected to reach USD 1,125.66 billion by 2025, according to a new report by Grand View Research, Inc. The market is anticipated to register a CAGR of 11.6% from 2021 to 2025. The increasing demand for environment-friendly vehicles and increasingly stringent government regulations regarding vehicular emission are expected to favor the demand for automotive powertrains in the market. Moreover, technological advancements in powertrain systems to enhance the vehicle's efficiency are anticipated to boost market growth prospects over the forecast period.

The adoption rate and pace of evolution of automotive powertrain vary across regions according to purchase subsidies, regulatory differences, road pricing, fuel taxation policy, state support, and consumer preferences. In Europe and countries such as China, South Korea, and Japan, stringent regulations are expected to make OEMs shift their focus on electrified powertrain options. Other significant factors that constitute the evolution of powertrain include developing charging infrastructure in different regions globally.

Automotive Powertrain Market Report Scope

Report Attribute

Details

Market size value in 2021

USD 725.45 billion

Revenue forecast in 2025

USD 1,125.66 billion

Growth Rate

CAGR of 11.6% from 2021 to 2025

Base year for estimation

2020

Historical data

2015 - 2019

Forecast period

2021 - 2025

Increasing vehicle sales and the growing adoption of automated transmission vehicles in emerging countries such as India, China, Indonesia, Japan, and Brazil, are expected to drive the market. The substantial rise in the purchasing power of consumers has increased the demand for state-of-the-art motor vehicles, driving the demand for upgraded systems. The rising use of All Wheel Drive in SUVs in emerging regions is also expected to support the growth of the powertrain market. The growing demand for AWD-equipped vehicles in the Asia Pacific region is expected to boost the growth of the all-wheel-drive system market.

The COVID-19 pandemic has hampered the growth prospects of several industries in 2020; powertrain manufacturers are facing a year-on-year decline in unit volumes sales and revenues. For instance, BorgWarner Inc., a prominent market player in the electric powertrain market, witnessed a decrease in the e-Propulsion & Drivetrain business segment. However, the demand for vehicles with upgraded safety features is likely to increase post-pandemic. Since automotive powertrain plays a vital role in automobiles, the market could regain momentum. Furthermore, despite the pandemic, the growing demand for electric vehicles is anticipated to boost the demand for automotive powertrains.

Request a free sample copy or view report summary: Automotive Powertrain Market Report

Automotive Powertrain Market Report Highlights

  • In terms of vehicle type, the commercial vehiclesegment is expected to expand at the highest CAGR of around 11.7% over the forecast period. This can be attributed to the increasing demand for a unified supply chain network connecting multiple transportation modes, including freight rail, air, and express delivery services, maritime transport, and truck transport
  • In terms of propulsion type, the ICE segment dominated the market in 2020 and is anticipated to value at more than USD 902.91 billion by 2028. This can be attributed to the price difference between ICEs and EVs and inadequate charging infrastructure
  • The Asia Pacific regional market held the dominant market share in 2020, with the China market being a significant contributor. China remains the largest manufacturer of automobiles and automotive markets across the globe. In 2020, China ranked first in terms of the production of passenger cars globally, which stood at nearly 21 million

Access Press Release@ https://www.grandviewresearch.com/press-release/global-automotive-powertrain-market

Automotive Powertrain Market Segmentation

Grand View Research has segmented the global automotive powertrain market based on vehicle type, propulsion type, and region:

Automotive Powertrain Vehicle Type Outlook (Volume, Thousand Units; Revenue, USD Billion, 2015 - 2025)

  • Passenger Vehicle
  • Commercial Vehicle

Automotive Powertrain Propulsion Type Outlook (Volume, Thousand Units; Revenue, USD Billion, 2015 - 2025)

  • ICE
    • Gasoline
    • Diesel
    • Natural Gas Vehicle
  • BEV
    • PHEV
    • Electric Vehicle

Automotive Powertrain Regional Outlook (Volume, Thousand Units; Revenue, USD Billion, 2015 - 2025)

  • North America
    • US.
    • Canada
  • Europe
    • Germany
    • UK.
  • Asia Pacific
    • Greater China
    • Japan
    • India
    • South Korea
  • Latin America
  • Middle East & Africa

List of Key Players in the Automotive Powertrain Market

  • BorgWarner
  • Continental AG
  • Magna International Inc.
  • Marelli Holdings Co., Ltd.
  • Mitsubishi Electric Corp
  • Nidec Corporation
  • Robert Bosch GmbH
  • Schaeffler AG
  • Valeo
  • ZF Friedrichshafen AG

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Dry-cleaning And Laundry Services Market Witness Excellent Revenue Growth During 2023-2030: Grand View Research Inc

 Dry-cleaning And Laundry Services Market Growth & Trends

The global dry-cleaning and laundry services market size is estimated to reach USD 118.71 billion by 2030, registering a CAGR of 7.0% from 2023 to 2030, according to a new report by Grand View Research, Inc. The significance of having a clean and hygienic living environment is becoming more widely acknowledged. This is crucial for bedding products like duvets, which can harbor pollutants like dust mites and allergies. More consumers are turning to dry-clean and laundry services for better cleaning and sanitization of clothing and duvets.Modern consumers are increasingly preferring cashless payment options, which is having a significant impact on the laundry industry. As a result, many laundry providers and dry-cleaning services are shifting to card payment systems.

These systems offer added convenience to both business owners and customers by eliminating the need for change, while also improving safety and fostering customer loyalty. Furthermore, technological advancements have enabled machines to work in tandem with chemical, pump, ozone, and UV disinfection systems, which is especially beneficial during the COVID-19 pandemic.  With the growing concerns about high utility bills and the environment, energy efficiency has become increasingly important for investors and customers alike. Commercial laundry equipment has made significant strides in recent years, offering greater control and shorter dry times that reduce energy consumption and lower utility bills.

Dry-cleaning And Laundry Services Market Report Scope

Report Attribute

Details

Market size value in 2023

USD 73.55 billion

Revenue forecast in 2030

USD 118.71 billion

Growth rate

CAGR of 7.0% from 2023 to 2030

Base year for estimation

2022

Historical data

2017 - 2021

Forecast period

2023 - 2030

This has spurred many laundry facilities and dry-cleaning services to upgrade their equipment, not only to save money but also to attract more eco-conscious customers. The latest commercial laundry equipment is designed to be more energy-efficient than ever before. These machines use less water, have shorter dry times, and provide more controls to adjust levels and temperature, all of which help reduce energy consumption, lower utility bills, and make it easier to run an energy-efficient laundry facility. Many key players have started upgrading their commercial laundry equipment to improve energy efficiency and attract more environment-conscious customers.

By reducing fossil fuel usage, lowering greenhouse gas emissions, and conserving natural resources, energy-efficient laundry equipment is essential for businesses that want to reduce their environmental impact and save money on utility bills.Increasing adoption of online services by the overall consumer group has been a major trend in the industry and helping businesses grow. In addition, the convenience and effortlessness provided by such services is another aspect that is leading toward their high adoption. High disposable incomes and rising expenditure on personal hygiene are acting as major catalysts for laundry facilities and dry-cleaning services, influencing their acceptance in the U.S.

Subscription packages and offers are expected to further popularize these services among consumers. Many subscription-based laundry services use high-quality cleaning products and equipment to ensure that the laundry is cleaned thoroughly and effectively and to give consumers one less chore to complete in their day-to-day lives. Laundryheap is a subscription-based laundry service that operates in several major cities around the world, including London, Paris, and Dubai. Customers can schedule laundry pickups and deliveries through the Laundryheap app and can choose from a variety of services, including wash & fold, dry cleaning, and ironing.

Request a free sample copy or view report summary: Dry-cleaning And Laundry Services Market Report

Dry-cleaning And Laundry Services Market Report Highlights

  • Asia Pacific dominated the global market in 2022. The market is anticipated to be driven by the presence of rapidly developing economies like India and China, a growing working population, and rising spending on cleaning services
  • The commercial setting segment is estimated to register the fastestCAGR from 2023 to 2030. Commercial laundry services are increasingly adopting sustainable practices, such as using eco-friendly detergents and reducing water usage. This is particularly important for businesses that want to minimize their environmental impact
  • To maintain market share, industry participants are broadening their service offerings. For instance, in March 2021, Alliance Laundry Systems LLC introduced a new generation of washers featuring touchscreen controls and full connectivity options for select Primus and IPSO models
  • The touchscreen control platform offers exceptional versatility for laundry customers and also helps reduce touchpoints

Access Press Release@ https://www.grandviewresearch.com/press-release/global-dry-cleaning-laundry-services-market

Dry-cleaning And Laundry Services Market Segmentation

Grand View Research has segmented the global dry-cleaning and laundry services market on the basis of services, application, and region:

Dry-cleaning And Laundry Services Outlook (Revenue, USD Million, 2017 - 2030)

  • Laundry
  • Dry Cleaning
  • Duvet Cleaning

Dry-cleaning And Laundry Services Application Outlook (Revenue, USD Million, 2017 - 2030)

  • Residential
  • Commercial

Dry-cleaning And Laundry Services Regional Outlook (Revenue, USD Million, 2017 - 2030)

  • North America
    • US.
    • Canada
  • Europe
    • Germany
    • France
    • UK.
    • Spain
    • Italy
  • Asia Pacific
    • China
    • India
    • Japan
  • Central & South America
    • Brazil
  • Middle East & Africa
    • South Africa

List of Key Players in Dry-cleaning And Laundry Services Market

  • Alliance Laundry Systems LLC
  • The Huntington Company
  • ZIPS Dry Cleaners
  • Alsco Pty Ltd.
  • Rinse, Inc.
  • Marberry Cleaners & Launderers, Inc.
  • Tide Dry Cleaners (Procter & Gamble)
  • City Dry Cleaning Company
  • East Rand Cleaners
  • Cleanly

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Thursday, 3 August 2023

Retinal Disorder Treatment Market Expected To Propel Industry Growth By 2030: Grand View Research Inc.

 Retinal Disorder Treatment Market Growth & Trends

The global retinal disorder treatment market size is expected to reach USD 25.69 billion, expanding at a CAGR of 9.3% from 2023 to 2030, according to a new report by Grand View Research, Inc. Growth in the market is fueled by the increasing prevalence of retinal disorders around the world and the unmet need for affordable and efficient treatments. Furthermore, improved funding by regulatory bodies for R&D associated with ocular disorders is expected to further drive market growth.

Retinal diseases are one of the leading causes of visual impairment among the global population. According to WHO, in 2022, a near or distant vision impairment affects at least 2.2 billion people worldwide. Nearly half of these cases, or around 1 billion, involved vision impairments that either could have been avoided or are still unaddressed. Factors such as changing lifestyles, increased life expectancy, and escalating prevalence of systemic diseases like hypertension and diabetes mellitus are the most common causes of retinal disorders. This demonstrates an unmet need among retinal disorder patients for treatment of the condition.

Retinal Disorder Treatment Market Report Scope

Report Attribute

Details

Market size value in 2023

USD 13.69 billion

Revenue forecast in 2030

USD 25.69 billion

Growth rate

CAGR of 9.3% from 2023 to 2030

Base year for estimation

2022

Historical data

2018 - 2021

Forecast period

2023 - 2030

The rising geriatric population is acting as a driver for the market; age-related macular degeneration (AMD) is one of the leading causes of vision loss in people aged over 65 years. AMD is characterized by the degeneration of an area of the retina known as the macula, which is responsible for central vision. The growing elderly population is expected to create a wider patient pool for the treatment of AMD. For instance, according to a WHO report in 2021, by 2030, 1 in every 6 people in the world will be aged 60 years or over. Furthermore, over this period of time, the population aged over 60 years is expected to increase from 1 billion in 2020 to 1.4 billion.

The high cost associated with retinal disorder treatment poses a threat to the growth of the market. However, increasing efforts from key players operating in the market for developing new products for the enhancement of their product pipeline is expected to drive the market. For instance, in January 2022, Genentech’s Vabysmo was approved by the FDA, the first-in-class bispecific antibody for the treatment of wet age-related macular degeneration and diabetic macular edema. The launch of novel products is expected to propel market growth.

Request a free sample copy or view report summary: Retinal Disorder Treatment Market Report

Retinal Disorder Treatment Market Report Highlights

  • By type, the macular degeneration segment held the largest market share in 2022, which is attributable to its high prevalence, rising awareness about the disease, and promising pipeline products
  • Eye drops dosage form segment is projected to grow at the fastest rate over the forecast period due to its high adoption and ease of use
  • Hospital pharmacies held a dominant share of the distribution channel segment in 2022 due to the ease of access and availability of patient records
  • North America dominated the global market in 2022 and is expected to grow considerably in the future, owing to the rising prevalence of retinal disorders and the increasing consumer awareness about retinal disorders
  • A few of the key players include Regeneron Pharmaceuticals Inc., Shire (Takeda Pharmaceutical Company Limited), Graybug Vision, Inc., Bayer AG, Santen Pharmaceutical Co., Ltd., and Genentech, Inc.

Access Press Release@ https://www.grandviewresearch.com/press-release/global-retinal-disorder-treatment-market

Retinal Disorder Treatment Market Segmentation

Grand View Research has segmented the global retinal disorder treatment market based on type, dosage form, distribution channel, and region:

Retinal Disorder Treatment Type Outlook (Revenue, USD Million, 2018 - 2030)

  • Macular Degeneration
    • Dry Macular Degeneration
    • Wet Macular Degeneration
  • Diabetic Retinopathy
  • Others

Retinal Disorder Treatment Dosage Form Outlook (Revenue, USD Million, 2018 - 2030)

  • Gels
  • Eye Solutions
  • Capsules & Tablets
  • Eye Drops
  • Ointments

Retinal Disorder Treatment Distribution Channel Outlook (Revenue, USD Million, 2018 - 2030)

  • Hospital Pharmacy
  • Online Pharmacy
  • Retail Pharmacy

Retinal Disorder Treatment Regional Outlook (Revenue, USD Million, 2018 - 2030)

  • North America
    • US.
    • Canada
  • Europe
    • UK.
    • Germany
    • France
    • Italy
    • Spain
    • Denmark
    • Sweden
    • Norway
  • Asia Pacific
    • Japan
    • China
    • India
    • South Korea
    • Thailand
    • Australia
  • Latin America
    • Brazil
    • Mexico
    • Argentina
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE
    • Kuwait

List of Key Players in the Retinal Disorder Treatment Market

  • Santen Pharmaceutical Co., Ltd.
  • Regeneron Pharmaceuticals Inc.
  • Graybug Vision, Inc.
  • Shire (Takeda Pharmaceutical Company Limited)
  • Bayer AG
  • Allergan plc. (AbbVie Inc.)
  • Genentech, Inc. (F. Hoffmann-La Roche Ltd.)
  • Acucela Inc.
  • Pfizer, Inc.
  • Kubota Pharmaceutical Holdings Co., Ltd.,

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Socks Market Top Players, Analysis And Forecast Till 2030: Grand View Research Inc.

 Socks Market Growth & Trends

The global socks market is expected to reach USD 73.6 billion by 2030, registering a CAGR of 6.4% over the forecast period, according to a new report by Grand View Research, Inc. The increasing trend of formal clothing among white-collar professionals is anticipated to play a vital role in boosting product demand. This, in turn, is estimated to increase market growth over the forecast period. Furthermore, growing spending on health, as well as fitness, is anticipated to fuel the demand for different footwear accessories that include sports socks and ankle socks. Over the last couple of years, different healthcare professionals have increased their spending on publishing several research papers on keeping the feet healthy on account of the growing occurrences of foot disorders related to diabetes.

As a result, some of the companies including Dr. Oxyn and Podolite have launched customized diabetic socks to reduce the risk of foot ulcers, which function as a root cause of infections, or amputation. The presence of corporate offices in emerging economies including China, Bangladesh, India, and Mexico, due to supportive policies to promote investments at a domestic level, is expected to remain a favorable factor for industry growth. However, increasing demand for footwear, such as sandals and slippers, is hindering the growth of this market. Rising demand for specialized socks along with the increasing awareness about fitness & health in various regions will create development opportunities for the industry over the forecast period.

Socks Market Report Scope

Report Attribute

Details

Market size value in 2023

USD 47.1 billion

Revenue forecast in 2030

USD 73.6 billion

Growth rate

CAGR of 6.4% from 2023 to 2030

Base year for estimation

2022

Historical data

2017 - 2021

Forecast period

2023 - 2030

Industry development is likely to be higher in emerging regions due to the increasing penetration of corporate offices, which creates ample growth opportunities for the market. The COVID-19 pandemic has impacted the industry, as the product demand was decreased globally. With the lockdown and movement restrictions, socks sales were drastically impacted. However, top players reinvented their product lines and most of them utilized the lockdown period to innovate their production and retail approach. The demand for socks is significantly influenced by changing fashion and style trends. As people seek to stay up-to-date with the latest trends and styles, they often purchase new socks that match their fashion preferences. Socks with colorful patterns or bold designs may be popular in one season, while plain and classic styles may be preferred in another.

This trend-driven demand creates opportunities for companies to introduce new sock designs and styles to capture consumer interest and generate sales. Socks designed for specific sports or fitness activities are gaining popularity among enthusiasts. These specialized socks offer benefits, such as improved performance, increased comfort, and reduced risk of injury. For instance, compression socks worn during exercise can improve blood circulation and help prevent swelling and soreness in the feet and legs. As more people engage in sports and fitness activities, the demand for specialized socks is expected to grow, providing opportunities for companies that cater to this niche market.

Request a free sample copy or view report summary: Socks Market Report

Socks Market Report Highlights

  • Casual socks are the leading product segment and held a share of almost 54% of the global revenue in 2022. Many brands are using sustainable and eco-friendly materials, while others are incorporating compression or moisture-wicking technologies into their socks
  • The athletic socks segment is projected to accelerate at a CAGR of 6.9% during the forecast period. This growth can be attributed to several factors, such as the increasing popularity of athleisure wear, rising awareness about the importance of comfortable & supportive socks for athletic performance, and the growth of e-commerce platforms that make it easier for consumers to purchase athletic socks
  • Men’s socks held a revenue share of 62.8% in 2022. The segment is likely to continue its growth in the coming years as consumers have become more aware of the importance of high-quality socks for both comfort and style. The women’s socks market is progressing rapidly and is expected to improve by 1.6x by 2030. One of the reasons for the growth in the women's socks market is the changing fashion trends. Socks are no longer seen as just a functional item but also as a fashion accessory. As a result, women are now looking for socks that not only provide comfort but also look stylish
  • Hypermarkets and supermarkets are the leading distribution channel for socks and held a share of 56.7% of the global revenue in 2022. However, customers are levitating towards online retail channels and thus, the online segment is expected to register a CAGR of 7.1% during the forecast period

Access Press Release@ https://www.grandviewresearch.com/press-release/global-socks-market

Socks Market Segmentation

Grand View Research has segmented the global socks market on the basis of product, end-use, distribution channel, and region:

Socks Product Outlook (Revenue, USD Million, 2017 - 2030)

  • Casual
  • Formal
  • Athletic

Socks End-use Outlook (Revenue, USD Million, 2017 - 2030)

  • Men
  • Women
  • Children

Socks Distribution Channel Outlook (Revenue, USD Million, 2017 - 2030)

  • Hypermarkets And Supermarkets
  • Convenience Stores
  • Online

Socks Regional Outlook (Revenue, USD Million, 2017 - 2030)

  • North America
    • US.
  • Europe
    • UK
    • Germany
  • Asia Pacific
    • China
    • India
  • Central and South America
    • Brazil
  • Middle East & Africa
    • South Africa

List of Key Players in the Socks Market

  • Nike Inc.
  • Puma S.E.
  • Adidas A.G.
  • Asics Corp.
  • Skechers USA, Inc.
  • Hanesbrands Inc.
  • Under Armour, Inc.
  • VF Corp.
  • Jockey International Inc.
  • Drymax Technologies Inc.

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Enterprise Architecture Tools Market Overview, Analysis And Forecast To 2028: Grand View Research Inc.

 Enterprise Architecture Tools Market Growth & Trends

The global enterprise architecture tools market size is estimated to reach USD 1.41 billion by 2028, expanding at a CAGR of 4.9% from 2021 to 2028, according to a new study by Grand View Research, Inc. Increasing importance of affiliate enterprise IT solutions and business-driven architecture methods are expected to boost the market growth. The business is being supported by the enterprise architecture tools, which add large data capabilities and save time meanwhile reducing the process time. These factors are anticipated to increase the use of enterprise architecture tools by businesses, subsequently driving the market growth globally.

Enterprise architecture tools offer an added advantage of aiding strategic decision-making and integrating data across industries. The growing demand for all-in-one platforms, implementation of effective business strategies, understanding of strategic architecture, and assessment of possibilities and business risks are expected to boost the demand for enterprise architecture tools. Moreover, enterprise architecture tools also help and support data integration and facilitate better IT and strategic decisions, thereby, driving the market growth globally.

Enterprise Architecture Tools Market Report Scope

Report Attribute

Details

Market size value in 2021

USD 1.01 billion

Revenue forecast in 2028

USD 1.41 billion

Growth rate

CAGR of 4.9% from 2021 to 2028

Base year for estimation

2020

Historical data

2018 - 2019

Forecast period

2021 - 2028

Some challenges in the market growth include data theft, security of data, low availability of skilled labor, and higher costs of tools, which are projected to hamper the market growth. In recent years, data thefts have increased, and the average cost of a data breach was estimated to be around USD 3.92 million in 2019. Thus, companies are expected to deploy a variety of software to reduce data thefts and increase security. Furthermore, with technological advancements and vendors investing in enterprise tools, companies are anticipated to mitigate flaws in architecture tools integration. This is expected to increase the market growth despite the challenges.

To be competitive, market participants use differentiation techniques and focus on introducing new products. For instance, in September 2020, Mega International introduced HOPEX V4, which included HOPEX 360 (a new enterprise portal), Risk Management, IT Business Management, and Information Architecture. Moreover, collaborations, partnerships, mergers, and acquisitions are also expected to help companies in gaining market shares and increasing investments in the market for enterprise architecture tools. For instance, in August 2020, both Software AG and du from Emirates Integrated Telecommunications Company (EITC) collaborated to provide a subscription-based licensing model for IoT services to their corporate clients. The companies were able to address difficult IoT incorporation for enterprises in the UAE through this partnership.

Request a free sample copy or view report summary: Enterprise Architecture Tools Market Report

Enterprise Architecture Tools Market Report Highlights

  • The security architecture segment is expected to witness significant growth over the forecast period. The increasing number of data threats is expected to lead to the deployment of a greater number of security architectures as they include tools, technologies, and processes that are used to protect a business from external threats
  • The cloud segment is anticipated to expand at the highest CAGR from 2021 to 2028. The popularity of cloud technology among cost-sensitive customers and small and medium enterprises is anticipated to boost the adoption of cloud enterprise architecture tools
  • The small and medium enterprise segment is expected to register the highest CAGR from 2021 to 2028. Factors such as the growing number of providers and the demand for business-driven tools and solutions have boosted the adoption across SMEs
  • The healthcare segment is anticipated to emerge as the fastest-growing end-use segment over the forecast period. Maximization of ICT advantages, integration of resources, integration of data, and reduction of unnecessary cost are the key factors driving the healthcare segment growth
  • Asia Pacific is anticipated to emerge as the fastest-growing regional market over the forecast period. China, Japan, and India are the key countries characterized by the maximum deployment of architecture tools in organizations. The growing adoption of enterprise architecture tools among businesses to implement effective corporate strategies in various enterprise tasks and practices is expected to boost market growth in the Asia Pacific region

Access Press Release@ https://www.grandviewresearch.com/press-release/global-enterprise-architecture-tools-market

Enterprise Architecture Tools Market Segmentation

Grand View Research has segmented the global enterprise architecture tools market based on solution, deployment, enterprise size, end use, and region:

Enterprise Architecture Tools Solution Outlook (Revenue, USD Million, 2018 - 2028)

  • Application Architecture
  • Data Architecture
  • Security Architecture
  • Infrastructure Architecture
  • Others

Enterprise Architecture Tools Deployment Outlook (Revenue, USD Million, 2018 - 2028)

  • On-premise
  • Cloud

Enterprise Architecture Tools Enterprise Size Outlook (Revenue, USD Million, 2018 - 2028)

  • Small & Medium Enterprises (SMEs)
  • Large Enterprises

Enterprise Architecture Tools End-use Outlook (Revenue, USD Million, 2018 - 2028)

  • BFSI
  • Consumer Goods & Retail
  • IT & Telecom
  • Manufacturing
  • Healthcare
  • Others

Enterprise Architecture Tools Regional Outlook (Revenue, USD Million, 2018 - 2028)

  • North America
    • US.
    • Canada
  • Europe
    • Germany
    • UK.
  • Asia Pacific
    • China
    • India
    • Japan
  • Latin America
    • Brazil
  • MEA

List of Key Players in the Enterprise Architecture Tools Market

  • Software AG
  • Avolution
  • BiZZdesign
  • MEGA International
  • BOC Group
  • Orbus Software
  • QualiWare
  • LeanIX
  • erwin
  • ValueBlue

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Fetal Monitoring Equipment Market is Thriving $6.16 Billion Revenue by 2030: Grand View Research Inc.

  Fetal Monitoring Equipment Market Growth & Trends The global  fetal monitoring equipment market  size is anticipated to reach USD 6.16...